Easy Bio USA, Inc. announced that it will issue 35,500,000 common shares through third-party capital increase at an issue price of KRW 1,333.2 per share for gross proceeds of KRW 47,328,600,000 on February 16, 2024. The transaction will include participation from returning investor, EASY BIO,Inc. The transaction has been approved by the board of directors. The company is expected to close the transaction on February 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,075 KRW | -1.09% | +4.35% | +12.57% |
Feb. 16 | Easy Bio USA, Inc. announced that it expects to receive KRW 47.3286 billion in funding from EASY BIO,Inc. | CI |
2022 | EASY BIO,Inc.(KOSDAQ:A353810) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+12.57% | 101M | |
+11.33% | 11.43B | |
-0.75% | 5.77B | |
-4.08% | 4.87B | |
-23.66% | 2.58B | |
-5.06% | 1.75B | |
-24.53% | 1.11B | |
-23.66% | 882M | |
-18.46% | 865M | |
+24.67% | 855M |
- Stock Market
- Equities
- A353810 Stock
- News EASY BIO,Inc.
- Easy Bio USA, Inc. announced that it expects to receive KRW 47.3286 billion in funding from EASY BIO,Inc.